Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07417163 · ClinicalTrials.gov registry record · NA

LiverSleep: A Behavioral Sleep Intervention for Patients With Cirrhosis and Insomnia

A NA study of Insomnia and Cirrhosis, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT07417163: Recruiting NA study of Insomnia and Cirrhosis, sponsored by Massachusetts General Hospital.

NCT07417163 is a NA study of Insomnia and Cirrhosis that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 10 participants, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07417163, a NA study of Insomnia and Cirrhosis, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

This is a pilot trial to test the feasibility and acceptability of a virtual cognitive behavioral program for insomnia for patients with cirrhosis.

Primary Outcome

Percent of those screened and eligible who enroll (i.e., sign consent and complete baseline). Reasons for ineligibility, refusal, or drop out, will also be measured along with session attendance.

Conditions Studied

Interventions

  • BEHAVIORAL Adapted Virtual Insomnia Program

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2026-02-26
Est. Completion 2026-07
Phase NA
Massachusetts General Hospital

2,032 total trials

What NCT07417163 shows while recruiting

NCT07417163 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (94% lower).

The record links to 2 conditions, with Insomnia appearing as the primary indexed condition, and to 1 intervention - of which Adapted Virtual Insomnia Program is the first listed.

NCT07417163 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT07417163 about?

NCT07417163 is a clinical study titled "LiverSleep: A Behavioral Sleep Intervention for Patients With Cirrhosis and Insomnia". This is a pilot trial to test the feasibility and acceptability of a virtual cognitive behavioral program for insomnia for patients with cirrhosis.

What is the current status of trial NCT07417163?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2026-02-26. Estimated completion is 2026-07.

What conditions does trial NCT07417163 study?

This clinical trial studies the following conditions: Insomnia, Cirrhosis.

What interventions are being tested in trial NCT07417163?

The interventions under investigation include: Adapted Virtual Insomnia Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT07417163?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07417163 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Insomnia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07417163's enrollment target sits among peer trials

10 148th of 151 higher than 3 of 151 other Insomnia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Insomnia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07417163, the US trial registry maintained by the National Library of Medicine. NCT07417163 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.